The Food and Drug Administration ( FDA ) has approved emergency use authority ( EUA ) for a third COVID-19 vaccine dose or booster shot of the Pfizer and Moderna COVID-19 vaccines for moderate to severe immunocompromised people who are 12 and older. The Centers for Disease Control and Prevention ( CDC ) and Advisory Committee on Immunization Practices are meeting throughout today ( Friday ) to further discus recommendations for booster vaccines for these individuals .
“ The reason that immunocompromised people will need an extra vaccine is that their immune systems do n’t respond adenine well to the initial doses of the vaccine and the reception they do have wears off over clock time, ” says Dr. Melanie Swift, co-chair of Mayo Clinic ‘s COVID-19 Vaccine Allocation and Distribution Work Group.
immunocompromised people account for approximately 2.7 % of U.S. adults, according to the CDC. This means they have a weakened immune system.
“ This means the immune system is not competent to fight off infections. This could be due to a disease or medicine, ” says Dr. Swift. “ People with a weakened immune system have a more difficult time fighting off infection than a healthy person. ”
Immunosuppressed is much used to describe immunocompromised.
“ immunosuppressed means basically the same thing, but it normally refers to taking a medicine that suppresses the immune system, ” Dr. Swift explains.
The immune arrangement ‘s function is to protect the body by staving off disease-causing germs, viruses and parasites, equally well as cell changes that could lead to disease, such as cancer. The system is a building complex net made up of organs, tissues, cells and proteins throughout the consistency.
People can be immunocompromised for respective reasons. Patients may have certain diseases, or the practice of medications or aesculapian treatments may suppress a person ‘s immune organization, such as :
- Chronic Lymphocytic Leukemia.
- Chronic Myeloid Leukemia.
- Advanced or untreated HIV/AIDS.
- Certain genetic disorders, such as congenital agammaglobulinemia or congenital immunoglobulin A deficiency.
- Anti-cancer drugs.
- Post transplant medications.
- Immunosuppressant drugs used for autoimmune conditions.
- Corticosteroids at high doses.
Treatments may include cram kernel transplant, radiation sickness therapy, solid organ transplant ( due to the medications used ) or hemodialysis.
The most important way to help those who are immunocompromised or immunosuppressed is to get vaccinated for COVID-19 .
“ The COVID-19 vaccines are highly effective in preventing severe disease and hospitalization, which is specially crucial in bad patients. With the stream banquet of the delta random variable, high residential district inoculation rates have never been more crucial. If you have n’t had your first acid yet, now is the time, ” says Dr. Swift .
The Mayo Clinic COVID-19 Vaccine Allocation and Distribution Work Group is planning to administer promoter doses of COVID-19 vaccines to Mayo Clinic patients and staff when approved by federal and department of state authorities.
For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was either recorded prior to COVID-19 or recorded in a nonpatient care area where social distancing and other safety protocols were followed.
Information in this post was accurate at the time of its posting. Due to the fluid nature of the COVID-19 pandemic, scientific understanding, along with guidelines and recommendations, may have changed since the original publication date .
For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org .
Learn more about tracking COVID-19 and COVID-19 trends .